Stephen Haynesworth, director of the Emerging Scholars Program, holds a primary appointment as an associate professor in the Department of Biology and secondary faculty appointments in the departments of orthopaedics and general medical sciences in the School of Medicine. He is the author of more than 30 peer-reviewed journal articles and holds 12 U.S. patents for inventions in his research field, adult stem cell technology. In 1992, Haynesworth co-founded Osiris Therapeutics, a publicly traded biotechnology company whose mission is to develop therapeutic stem cell products to regenerate damaged or diseased tissue and treat inflammatory diseases. The firm was acquired by Smith+Nephew, a global portfolio medical technology company, in 2019.
For more than 20 years, Haynesworth served as an associate dean in the College of Arts and Sciences, overseeing the Office of Research Administration and Support as well as facilities, information technology, and fellowship programs for students and faculty.
Haynesworth graduated from Shaw High School in East Cleveland. He received his bachelor of science degree in biology and a master of arts in education from Allegheny College in Meadville, Pennsylvania, and his doctorate in biology from Case Western Reserve. He conducted postdoctoral research in the Medical Research Division of the American Cyanamid Company and at CWRU before joining the faculty.